ORIFARM HEALTHCARE AS

0484 OSLO

Finances

Share Ownership

Return on Equity

46,17 %

Current Ratio

1,06

Debt-to-Equity Ratio

−0

Key figures (NOK)	2022	2021	2020	2019
Revenue	681 632 000	511 561 000	179 223 000	131 358 000
Net Income	8 091 000	5 479 000	960 000	473 000
Total Assets	253 007 000	130 003 000	44 183 000	34 096 000
Total Equity	17 526 000	9 434 000	3 955 000	2 995 000

Income (NOK)	2022	2021	2020	2019
Revenue	681 632 000	511 561 000	179 223 000	131 358 000
Expenditure	669 945 000	503 871 000	177 606 000	130 368 000
Operating Profit	11 687 000	7 690 000	1 616 000	989 000
Financial Income	1 121 000	335 000	317 000	316 000
Financial Costs	2 264 000	895 000	703 000	699 000
Financial Balance	−1 143 000	−560 000	−386 000	−383 000
Earnings Before Tax	10 545 000	7 131 000	1 231 000	606 000
Tax	2 453 000	1 652 000	271 000	133 000
Net Income	8 091 000	5 479 000	960 000	473 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	2 937 000	3 913 000	4 189 000	4 284 000
Total Current Assets	250 070 000	126 090 000	39 994 000	29 812 000
Total Assets	253 007 000	130 003 000	44 183 000	34 096 000
Total Retained Equity	17 026 000	8 934 000	3 455 000	2 495 000
Total Equity	17 526 000	9 434 000	3 955 000	2 995 000
Total Long-Term Debt	−1 000	0	0	0
Total Current Debt	235 482 000	120 569 000	40 228 000	31 100 000
Total Equity and Debt	253 007 000	130 003 000	44 183 000	34 096 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	668 030 000	511 561 000	179 223 000	131 358 000
Other Income	13 602 000	0	0	0
Revenue	681 632 000	511 561 000	179 223 000	131 358 000
Cost of Goods Sold	599 509 000	454 109 000	155 618 000	110 284 000
Salary Costs	0	0	0	0
Depreciation	833 000	799 000	724 000	728 000
Impairment	358 000	67 000	92 000	860 000
Expenditure	669 945 000	503 871 000	177 606 000	130 368 000
Operating Profit	11 687 000	7 690 000	1 616 000	989 000
Financial Income	1 121 000	335 000	317 000	316 000
Financial Costs	2 264 000	895 000	703 000	699 000
Financial Balance	−1 143 000	−560 000	−386 000	−383 000
Dividends	0	0	0	0
Net Income	8 091 000	5 479 000	960 000	473 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	2 937 000	3 913 000	4 189 000	4 284 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	2 937 000	3 913 000	4 189 000	4 284 000
Stock	0	0	0	0
Total Investments	0	0	0	0
Cash, Bank	0	0	0	0
Total Current Assets	250 070 000	126 090 000	39 994 000	29 812 000
Total Assets	253 007 000	130 003 000	44 183 000	34 096 000
Total Equity	17 526 000	9 434 000	3 955 000	2 995 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	−1 000	0	0	0
Creditors	196 980 000	14 647 000	87 000	4 253 000
Unpaid Taxes	23 744 000	17 476 000	9 952 000	5 633 000
Dividends	0	0	0	0
Other Current Debt	12 304 000	86 790 000	29 912 000	1 518 000
Total Current Debt	235 482 000	120 569 000	40 228 000	31 100 000
Total Equity and Debt	253 007 000	130 003 000	44 183 000	34 096 000

Financial indicators	2022	2021	2020	2019
Return on Equity	46,17 %	58,08 %	24,27 %	15,79 %
Debt-to-Equity Ratio	−0	0	0	0
Operating Profit Margin	1,71 %	1,5 %	0,9 %	0,75 %
Current Ratio	1,06	1,05	0,99	0,96
Quick Ratio	1,06	1,05	0,99	0,96
Equity Ratio	0,07	0,07	0,09	0,09
Gross Profit Margin	12,05 %	11,23 %	13,17 %	16,04 %